Macroaxis uses a strict editorial review process to publish stories and blog posts. Our publishers support our company and may receive a small commission when the partner links or references are utilized. Commissions do not affect the opinions or evaluations of our editorial team. The information our editors and media partners deliver is confidential and licensed for your sole use as a Macroaxis user. We reserve all rights to the content of this article, and therefore copying or distributing this story in whole or in part is strictly prohibited.
This list of potential positions covers Healthcare providers, hospitals. Major hospitals and healthcare providers in USA. Please note, we provide buy hold or sell recommendation only in the context of selected investment horizon assuming investor has average attitude towards taking risk. Please also consider using Portfolio Positions Ratings and Equity Ratings tools to further calibrate your research.
Story appears to be empty
Geo Group (GEO)
The company has Return on Asset of 0.0592 % which means that on every $100 spent on assets, it made $0.0592 of profit. This is way below average. In the same way, it shows a return on shareholders' equity (ROE) of 0.0873 %, implying that it generated $0.0873 on every 100 dollars invested. Geo's management efficiency ratios could be used to measure how well Geo manages its routine affairs as well as how well it operates its assets and liabilities. As of the 24th of April 2024, Return On Tangible Assets is likely to grow to 0.06. Also, Return On Capital Employed is likely to grow to 0.12. At this time, Geo's Return On Assets are very stable compared to the past year. This firm currently falls under 'Mid-Cap' category with a total capitalization of 1.9 B. Market capitalization usually refers to the total value of a company's stock within the entire market. To calculate Geo's market, we take the total number of its shares issued and multiply it by Geo's current market price. To manage market risk and economic uncertainty, many investors today build portfolios that are diversified across equities with different market capitalizations. However, as a general rule, conservative investors tend to hold large-cap stocks, and those looking for more risk prefer small-cap and mid-cap equities. At this time, the firm appears to be undervalued. Geo Group retains a regular Real Value of $3.99 per share. The prevalent price of the firm is $15.07. Our model calculates the value of Geo Group from evaluating the firm fundamentals such as Current Valuation of 3.61 B, return on equity of 0.0873, and Return On Asset of 0.0592 as well as inspecting its technical indicators and probability of bankruptcy. In general, most investors encourage obtaining undervalued assets and abandoning overvalued assets since, at some point, asset prices and their ongoing real values will come together.
NexgenRX (NXG.V)
At this time, NexgenRX's Net Tangible Assets are fairly stable compared to the past year. Other Assets is likely to climb to about 2.1 M in 2024, whereas Total Current Assets are likely to drop slightly above 13.1 M in 2024. NexgenRX's management efficiency ratios could be used to measure how well NexgenRX manages its routine affairs as well as how well it operates its assets and liabilities. The entity currently falls under 'Micro-Cap' category with a current market capitalization of 15.52 M. Market capitalization usually refers to the total value of a company's stock within the entire market. To calculate NexgenRX's market, we take the total number of its shares issued and multiply it by NexgenRX's current market price. To manage market risk and economic uncertainty, many investors today build portfolios that are diversified across equities with different market capitalizations. However, as a general rule, conservative investors tend to hold large-cap stocks, and those looking for more risk prefer small-cap and mid-cap equities.
Long Term Debt
537,474
At this time, NexgenRX's Long Term Debt is fairly stable compared to the past year.
Meta Growth Corp (NACNF)
The company has return on total asset (ROA) of (9.49) % which means that it has lost $9.49 on every $100 spent on assets. This is way below average. Similarly, it shows a return on equity (ROE) of (249.44) %, meaning that it generated substantial loss on money invested by shareholders. Meta Growth's management efficiency ratios could be used to measure how well Meta Growth manages its routine affairs as well as how well it operates its assets and liabilities. This firm currently falls under 'Micro-Cap' category with a current market capitalization of 25.28 M. Market capitalization usually refers to the total value of a company's stock within the entire market. To calculate Meta Growth's market, we take the total number of its shares issued and multiply it by Meta Growth's current market price. To manage market risk and economic uncertainty, many investors today build portfolios that are diversified across equities with different market capitalizations. However, as a general rule, conservative investors tend to hold large-cap stocks, and those looking for more risk prefer small-cap and mid-cap equities.
Caladrius Biosciences (CLBS)
The company has return on total asset (ROA) of (16.73) % which means that it has lost $16.73 on every $100 spent on assets. This is way below average. Similarly, it shows a return on equity (ROE) of (23.84) %, meaning that it generated substantial loss on money invested by shareholders. Caladrius Biosciences' management efficiency ratios could be used to measure how well Caladrius Biosciences manages its routine affairs as well as how well it operates its assets and liabilities. This firm currently falls under 'Micro-Cap' category with a current market capitalization of 25.49 M. Market capitalization usually refers to the total value of a company's stock within the entire market. To calculate Caladrius Biosciences's market, we take the total number of its shares issued and multiply it by Caladrius Biosciences's current market price. To manage market risk and economic uncertainty, many investors today build portfolios that are diversified across equities with different market capitalizations. However, as a general rule, conservative investors tend to hold large-cap stocks, and those looking for more risk prefer small-cap and mid-cap equities.
The company has Return on Asset of 0.0592 % which means that on every $100 spent on assets, it made $0.0592 of profit. This is way below average. In the same way, it shows a return on shareholders' equity (ROE) of 0.0873 %, implying that it generated $0.0873 on every 100 dollars invested. Geo's management efficiency ratios could be used to measure how well Geo manages its routine affairs as well as how well it operates its assets and liabilities. As of the 24th of April 2024, Return On Tangible Assets is likely to grow to 0.06. Also, Return On Capital Employed is likely to grow to 0.12. At this time, Geo's Return On Assets are very stable compared to the past year. This firm currently falls under 'Mid-Cap' category with a total capitalization of 1.9 B. Market capitalization usually refers to the total value of a company's stock within the entire market. To calculate Geo's market, we take the total number of its shares issued and multiply it by Geo's current market price. To manage market risk and economic uncertainty, many investors today build portfolios that are diversified across equities with different market capitalizations. However, as a general rule, conservative investors tend to hold large-cap stocks, and those looking for more risk prefer small-cap and mid-cap equities. At this time, the firm appears to be undervalued. Geo Group retains a regular Real Value of $3.99 per share. The prevalent price of the firm is $15.07. Our model calculates the value of Geo Group from evaluating the firm fundamentals such as Current Valuation of 3.61 B, return on equity of 0.0873, and Return On Asset of 0.0592 as well as inspecting its technical indicators and probability of bankruptcy. In general, most investors encourage obtaining undervalued assets and abandoning overvalued assets since, at some point, asset prices and their ongoing real values will come together.
NexgenRX (NXG.V)
At this time, NexgenRX's Net Tangible Assets are fairly stable compared to the past year. Other Assets is likely to climb to about 2.1 M in 2024, whereas Total Current Assets are likely to drop slightly above 13.1 M in 2024. NexgenRX's management efficiency ratios could be used to measure how well NexgenRX manages its routine affairs as well as how well it operates its assets and liabilities. The entity currently falls under 'Micro-Cap' category with a current market capitalization of 15.52 M. Market capitalization usually refers to the total value of a company's stock within the entire market. To calculate NexgenRX's market, we take the total number of its shares issued and multiply it by NexgenRX's current market price. To manage market risk and economic uncertainty, many investors today build portfolios that are diversified across equities with different market capitalizations. However, as a general rule, conservative investors tend to hold large-cap stocks, and those looking for more risk prefer small-cap and mid-cap equities.
Long Term Debt
537,474
At this time, NexgenRX's Long Term Debt is fairly stable compared to the past year.
Meta Growth Corp (NACNF)
The company has return on total asset (ROA) of (9.49) % which means that it has lost $9.49 on every $100 spent on assets. This is way below average. Similarly, it shows a return on equity (ROE) of (249.44) %, meaning that it generated substantial loss on money invested by shareholders. Meta Growth's management efficiency ratios could be used to measure how well Meta Growth manages its routine affairs as well as how well it operates its assets and liabilities. This firm currently falls under 'Micro-Cap' category with a current market capitalization of 25.28 M. Market capitalization usually refers to the total value of a company's stock within the entire market. To calculate Meta Growth's market, we take the total number of its shares issued and multiply it by Meta Growth's current market price. To manage market risk and economic uncertainty, many investors today build portfolios that are diversified across equities with different market capitalizations. However, as a general rule, conservative investors tend to hold large-cap stocks, and those looking for more risk prefer small-cap and mid-cap equities.
Caladrius Biosciences (CLBS)
The company has return on total asset (ROA) of (16.73) % which means that it has lost $16.73 on every $100 spent on assets. This is way below average. Similarly, it shows a return on equity (ROE) of (23.84) %, meaning that it generated substantial loss on money invested by shareholders. Caladrius Biosciences' management efficiency ratios could be used to measure how well Caladrius Biosciences manages its routine affairs as well as how well it operates its assets and liabilities. This firm currently falls under 'Micro-Cap' category with a current market capitalization of 25.49 M. Market capitalization usually refers to the total value of a company's stock within the entire market. To calculate Caladrius Biosciences's market, we take the total number of its shares issued and multiply it by Caladrius Biosciences's current market price. To manage market risk and economic uncertainty, many investors today build portfolios that are diversified across equities with different market capitalizations. However, as a general rule, conservative investors tend to hold large-cap stocks, and those looking for more risk prefer small-cap and mid-cap equities.
Building efficient market-beating portfolios requires time, education, and a lot of computing power!
The Portfolio Architect is an AI-driven system that provides multiple benefits to our users by leveraging cutting-edge machine learning algorithms, statistical analysis, and predictive modeling to automate the process of asset selection and portfolio construction, saving time and reducing human error for individual and institutional investors.
Rifka Kats is a Member of Macroaxis Editorial Board. Rifka writes about retail product and service companies from the perspective of a regular consumer and sophisticated investor at the same time. She is passionate about corporate ethics and equality in the workforce. View Profile
This story should be regarded as informational only and should not be considered a solicitation to sell or buy any financial products. Macroaxis does not express any opinion as to the present or future value of any investments referred to in this post. This post may not be reproduced without the consent of Macroaxis LLC. Please refer to our Terms of Use for any information regarding our disclosure principles.
Would you like to provide feedback on the content of this article?
You can get in touch with us directly or send us a quick note via email to editors@macroaxis.com
Did you try this?
Run Portfolio Manager Now
Portfolio Manager
State of the art Portfolio Manager to monitor and improve performance of your invested capital
Check out Correlation Analysis to better understand how to build diversified portfolios. Also, note that the market value of any private could be tightly coupled with the direction of predictive economic indicators such as signals in persons. You can also try the Stocks Directory module to find actively traded stocks across global markets.
